- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Public drug program spending in Canada by top drug classes 2017
Public drug program spending in Canada by top drug classes 2017
Top 10 drug classes by share of total public drug program spending in Canada in 2017*
by Matej Mikulic,
last edited
Nov 26, 2018
This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2017. In that year, 2.8 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
Top 10 drug classes by share of total public drug program spending in Canada in 2017*
Loading statistic...
| Share of total public drug program spending | |
|---|---|
| Tumour necrosis factor alpha inhibitors (anti-TNF drugs) | 8.2% |
| Antivirals for treatment of hepatitis C infections** | 5% |
| Antineovascularization agents*** | 4.6% |
| HMG-CoA reductase inhibitors (statins) | 2.8% |
| Other antipsychotics | 2.4% |
| Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics | 2.3% |
| Oral protein kinase inhibitors | 2.3% |
| Selective immunosuppressants | 2.2% |
| Proton pump inhibitors (PPIs) | 2.1% |
| Direct factor Xa inhibitors | 2% |
| Share of total public drug program spending | |
|---|---|
| Tumour necrosis factor alpha inhibitors (anti-TNF drugs) | 8.2% |
| Antivirals for treatment of hepatitis C infections** | 5% |
| Antineovascularization agents*** | 4.6% |
| HMG-CoA reductase inhibitors (statins) | 2.8% |
| Other antipsychotics | 2.4% |
| Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics | 2.3% |
| Oral protein kinase inhibitors | 2.3% |
| Selective immunosuppressants | 2.2% |
| Proton pump inhibitors (PPIs) | 2.1% |
| Direct factor Xa inhibitors | 2% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Nov 26, 2018
This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2017. In that year, 2.8 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
- Show sources information
- Show publisher information
- Release date
- November 2018
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
-
* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** Spending on antivirals for treatment of hepatitis C infections in Prince Edward Island is not included in NPDUIS.
*** Spending on ranibizumab and aflibercept (which accounted for 99.9% of spending on antineovascularization agents) in Nova Scotia, Manitoba and British Columbia, and the majority of this spending in Alberta, is funded through special programs and is not included in NPDUIS.
Free access to basic statistics
Source
- Show sources information
- Show publisher information
- Release date
- November 2018
More information
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
-
* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** Spending on antivirals for treatment of hepatitis C infections in Prince Edward Island is not included in NPDUIS.
*** Spending on ranibizumab and aflibercept (which accounted for 99.9% of spending on antineovascularization agents) in Nova Scotia, Manitoba and British Columbia, and the majority of this spending in Alberta, is funded through special programs and is not included in NPDUIS.
Other statistics on the topic
+Pharmaceutical Products & Market
Top pharmaceutical companies located in Canada in 2017, by revenue
+Pharmaceutical Products & Market
Pharmaceutical spending per capita in selected countries 2018
+Pharmaceutical Products & Market
Leading countries in life sciences sector M&As 2019
+Pharmaceutical Products & Market
Top 10 global pharmaceutical markets: growth 2012-2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Canadian pharmaceutical industry"
- Global positioning
The most important statistics
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Pharmaceutical spending per capita in selected countries as of 2018 (in U.S. dollars)Pharmaceutical spending per capita in selected countries 2018
- Drug products sales distribution in selected countries in 2017, by therapeutic class*Drug products sales distribution worldwide by country and therapy area 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*Leading countries in life sciences sector M&As 2019
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018Availability of new cancer drugs by country as of 2018
- Key figures
The most important statistics
- Total health expenditure on drugs in Canada from 2005 to 2018 (in billion Canadian dollars)Health expenditures on drugs in Canada 2005-2018
- Pharmaceutical sales from patented and non-patented drugs in Canada from 2004 to 2017 (in billion Canadian dollars)Pharmaceutical sales from patented and non-patented drugs in Canada 2004-2017
- Total pharmaceutical R&D expenditures in Canada from 2004 to 2017 (in billion Canadian dollars)Spending on R&D from pharmaceutical industry in Canada 2004-2017
- Employment in Canadian pharmaceutical industry manufacturing from 2005 to 2018*Employment in pharmaceutical manufacturing in Canada 2005-2018
- Top 10 pharmaceutical companies in Canada in 2017, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada in 2017, by revenue
- Pharmaceutical trade balance of Canada from 2004 to 2018 (in billion Canadian dollars)Pharmaceutical industry trade balance of Canada 2004-2018
- Regional comparison
The most important statistics
- Prescription drug expenditure in Canada by public drug plan in 2017/2018 (in million Canadian dollars)Prescription drug expenditure in Canada by public drug plan 2017/2018
- Distribution of current pharmaceutical R&D expenditures in Canada as of 2017, by region*Pharmaceutical current R&D spending distribution in Canada by region 2017
- Drug expenditure per capita in Canada by province in 2018 (in Canadian dollars)*Medication spending per capita in Canada by province 2018
- Generic share of total number of prescriptions in Canada by province in 2018Provincial generic medicine prescription market share in Canada 2018
- Employees in the pharmaceutical industry in Canada as of 2016, by provincePharmaceutical industry jobs in Canada by province 2016
- Average salary in Canada's pharmaceutical industry as of 2016, by province (in Canadian dollars)Pharmaceutical industry salary in Canada by province 2016
- Generics
The most important statistics
- Canadian prescribed generic medicine sales from 2006 to 2018 (in billion Canadian dollars)Generic Rx medicine sales in Canada 2006-2018
- Canadian generic and brand name medicine average retail price per prescription from 2004 to 2018 (in Canadian dollars)*Generic and brand name medicine average retail price in Canada 2004-2018
- Generic share of medicine prescriptions in Canada from 2006 to 2018Generic medicine prescription market share in Canada 2006-2018
- Generics share of prescribed drug costs in Canada from 2006 to 2018Generic medicine share of Canada's prescription costs 2006-2018
- Total generic drug savings in Canada in 2017, by province (in million Canadian dollars)Total generic drug savings Canada 2017, by province
- Private and public generic drug savings in Canada in 2017, by province (in million Canadian dollars)Private and public generic drug savings Canada 2017, by province
- Products and prices
The most important statistics
- Top 10 pharmaceutical products in Canada in 2017, by revenue (in million Canadian dollars)Top pharmaceutical products in Canada by revenue 2017
- Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*Cost per beneficiary of select drugs in Canada's public drug plans 2017-2018
- Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*Top biologic drugs by share of total drug costs in Canadian public plans 2017-2018
- Costs of biologic drugs in select Canadian public drug plans in 2017/2018 (in million Canadian dollars)Biologic drug costs in select Canadian public drug plans in 2017/2018
- Patented drugs price index changes in Canada from 1988 to 2017*Changes in price index of patented drugs in Canada 1988-2017
- Average foreign-to-Canadian price ratio for patented drugs as of 2017Average price ratio Canadian to foreign drug prices 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Public drug program spending in Canada by top 10 drug classes 2017
- Private sector funded drug spending Canada by top drug classes share 2013
- Private sector funded total drug spending in Canada by top drug classes 2013
- Public drug program spending in Canada by therapy share 2017
- Public drug program spending share for seniors in Canada by top drug classes 2017
- Public drug program spending for seniors in Canada by top drug classes 2017
- Public drug program spending for non-seniors in Canada by top drug classes 2017
- Share of paid beneficiaries of public drug program spending in Canada 2017
- Public drug program spending share for non-seniors in Canada by province 2017
- Public drug program spending share for seniors in Canada by province 2017
- Total public drug program spending in Canada by therapy 2017
- Public drug program spending share for generics in Canada by province 2017
- Public drug program spending share for non-seniors in Canada by top drug classes 2017
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Expenditures dedicated to drugs as share of total health spending in Canada 2005-2018
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Drug spending by Rx and non-Rx in Canada by type 1975-2018
Studies
- Prescribed Drug Spending in Canada, 2018
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Drug Use Among Seniors in Canada, 2016
- Prescribed Drug Spending in Canada, 2017
- Meds Entry Watch 2017
- CDER 2018 New Drug Therapy Approvals
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- The Oregon Medical Marijuana Program (April 2019)
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Patented Medicine Prices Review Board - Annual Report 2017
- Meds Entry Watch 2016
- Compass Rx - Annual Public Drug Plan Expenditure Report 2013/14
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- CDER 2017 New Drug Therapy Approvals
- Prescribed Drug Spending in Canada, 2013
Statistics on "Canadian pharmaceutical industry"
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Pharmaceutical spending per capita in selected countries as of 2018 (in U.S. dollars)
- Drug products sales distribution in selected countries in 2017, by therapeutic class*
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018
- Total health expenditure on drugs in Canada from 2005 to 2018 (in billion Canadian dollars)
- Pharmaceutical sales from patented and non-patented drugs in Canada from 2004 to 2017 (in billion Canadian dollars)
- Total pharmaceutical R&D expenditures in Canada from 2004 to 2017 (in billion Canadian dollars)
- Employment in Canadian pharmaceutical industry manufacturing from 2005 to 2018*
- Top 10 pharmaceutical companies in Canada in 2017, by revenue (in billion Canadian dollars)
- Pharmaceutical trade balance of Canada from 2004 to 2018 (in billion Canadian dollars)
- Prescription drug expenditure in Canada by public drug plan in 2017/2018 (in million Canadian dollars)
- Distribution of current pharmaceutical R&D expenditures in Canada as of 2017, by region*
- Drug expenditure per capita in Canada by province in 2018 (in Canadian dollars)*
- Generic share of total number of prescriptions in Canada by province in 2018
- Employees in the pharmaceutical industry in Canada as of 2016, by province
- Average salary in Canada's pharmaceutical industry as of 2016, by province (in Canadian dollars)
- Canadian prescribed generic medicine sales from 2006 to 2018 (in billion Canadian dollars)
- Canadian generic and brand name medicine average retail price per prescription from 2004 to 2018 (in Canadian dollars)*
- Generic share of medicine prescriptions in Canada from 2006 to 2018
- Generics share of prescribed drug costs in Canada from 2006 to 2018
- Total generic drug savings in Canada in 2017, by province (in million Canadian dollars)
- Private and public generic drug savings in Canada in 2017, by province (in million Canadian dollars)
- Top 10 pharmaceutical products in Canada in 2017, by revenue (in million Canadian dollars)
- Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*
- Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*
- Costs of biologic drugs in select Canadian public drug plans in 2017/2018 (in million Canadian dollars)
- Patented drugs price index changes in Canada from 1988 to 2017*
- Average foreign-to-Canadian price ratio for patented drugs as of 2017
- Top 10 drug classes by total public drug program spending in Canada in 2017 (in million Canadian dollars)*
- Top 10 drug classes by share of total drug spending funded by private sector in Canada in 2013*
- Top 10 drug classes by total drug spending funded by private sector in Canada in 2013 (in million Canadian dollars)
- Distribution of total public drug program spending in Canada by therapy in 2017*
- Distribution of top 10 drug classes in Canada by public drug program spending on seniors in 2017*
- Top 10 drug classes in Canada by total public drug program spending on seniors in 2017 (in million Canadian dollars)*
- Top 10 drug classes in Canada by total public drug program spending on non-seniors in 2017 (in million Canadian dollars)
- Distribution of paid beneficiaries from total public drug program spending in Canada in 2017*
- Distribution of total public drug program spending on non-seniors in Canada by province in 2017*
- Distribution of total public drug program spending on seniors in Canada by province in 2017*
- Total public drug program spending in Canada by therapy in 2017 (in million Canadian dollars)
- Generic drugs share of total public drug program spending in Canada by province in 2017*
- Distribution of top 10 drug classes in Canada by total public drug program spending on non-seniors in 2017*
- Expenditure on specialty medicines in the United States from 2014 to 2018, by type (in billion U.S. dollars)
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Expenditure on drugs as percent of total health spending in Canada from 2005 to 2018
- Distribution of drug dispensing costs by drug type in select public Canadian drug plans as of FY 2015/16*
- Expenditure on prescribed and non-prescribed drugs in Canada from 1975 to 2018 (in million Canadian dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.